Other studies have shown MMR to predict poor short-term survival in breast cancer patients treated with chemotherapy and have found associations between MMR, loss of heterozygosity, and the occurrence of secondary breast tumors [11,12,13]. Here, MRC1 is linked to breast carcinoma.